Mode of Action of Atrazine for Mammary Tumor Formation in the Female Sprague-Dawley Rat

The Triazine Herbicides

Volumn , Issue , 2008, Pages 399-411

  Eldridge, J Charles ^a   Wetzel, Lawrence T ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Syngenta Crop Protection Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751697755     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451167-6.50029-5     Document Type: Chapter

References (64)

1. Ashby J., Tinwell H., Stevens J.T., Pastoor T., Breckenridge C.B. The effects of atrazine on the sexual maturation of female rats. Regul. Toxicol. Pharmacol. 2002, 35:468-473.
2. Balaguer P., Joyeux A., Denison M.S., Vincent R., Gillesby B.E., Zacharewski T. Assessing the estrogenic and dioxinlike activities of chemicals and complex mixtures using in vitro recombinant reporter gene assays. Can. J. Physiol. Pharmacol. 1996, 74:216-222.
3. Beach J.E., Tyrey L., Everett J.W. Serum prolactin and LH in early phases of delayed and direct pseudopregnancy in the rat. Endocrinology 1975, 96:1243-1246.
4. Brusick D.J. An assessment of the genetic toxicity of atrazine: Relevance to health and effects. Mutat. Res. 1994, 317:133-144.
5. Bulger W.K., Muccitelli R.M., Kupfer D. Studies on the estrogenic activity of chlordecone (Kepone) in the rat: Effects on the uterine estrogen receptor. Mol. Pharmacol. 1979, 15:515-524.
6. Carr B.R. Disorders of the ovary and female reproductive tract. Williams' Endocrinology 1992, 733-798. Saunders, New York. 8th edn. J.D. Wilson, D.W. Foster (Eds.).
7. Connor K., Howell J., Chen I., Liu H., Berhane K., Sciarretta C., Safe S., Zacharewski T. Failure of chloro-s-triazine- derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fund. Appl. Toxicol. 1996, 30:93-101.
8. Cooper R.L., Stoker T.E., Goldman J.M., Parrish M.B., Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod. Toxicol. 1996, 10:257-264.
9. Cooper R.L., Stoker T.E., Tyrey L., Goldman J.M., McElroy W.K. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol. Sci. 2000, 53:292-307.
10. Cutts J.H., Noble R.L. Estrone-induced mammary tumors in the rat. I. Induction and behavior of tumors. Cancer Res. 1964, 24:1116-1123.
11. Danzo B.J. Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. Environ. Health Perspect. 1997, 105:306-310.
12. Eldridge J.C., McConnell R.F., Wetzel L.T., Tisdel M.O. Appearance of mammary tumors in atrazine-treated female rats: Probable mode of action involving strain-related control of ovulation and estrous cycling. Triazine Herbicides: Risk Assessment, ACS Symposium Series 683 1998, 414-423. American Chemical Society, Washington, DC, Chapter 32. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
13. Eldridge J.C., Wetzel L.T., Tyrey L. Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod. Toxicol. 1999, 13:491-499.
14. Eldridge J.C., Wetzel L.T., Stevens J.T., Simpkins J.W. The mammary tumor response in triazine-treated female rats: A threshold-mediated interaction with strain and species-specific reproductive senescence. Steroids 1999, 64:672-678.
15. Estes K.S., Simpkins J.W. Resumption of pulsatile luteinizing hormone release after aadrenergic stimulation in aging constant estrous rats. Endocrinology 1982, 111:1776-1784.
16. Estes K.S., Simpkins J.W. Age-related alternatives in catecholamine activity within microdissected brain regions of ovariect- omized Fischer 344 rats. J. Neurosci. Res. 1984, 11:405-417.
17. Estes K.S., Simpkins J.W., Kalra S.P. Normal LHRH neuronal function and hyperprolactinemia in old pseudopregnant Fischer 344 rats. Neurobiol. Aging 1982, 3:247-252.
18. Everett J.W., Tyrey L. Comparison of luteinizing hormone surge responses to ovarian steroids in cyclic and spontaneously persistent estrous rats of middle age. Biol. Reprod 1982, 26:663-672.
19. Finch C.E. Reproductive senescence in rodents: Factors in the decline of fertility and loss of regular estrous cycles. The Aging Reproductive System 1978, 159-192. Raven Press, New York. E.L. Schneider (Ed.).
20. Franekic J., Hulina G., Kniewald J., Alacevic M. Mutagenicity of deethyl-atrazine and its influence on S9 fraction activity. Mutat. Res. 1990, 234:384-385.
21. Friedmann A.S. Atrazine inhibition of testosterone production in rat males following prepubertal exposure. Reprod. Toxicol. 2002, 16:275-279.
22. Good N.E. Inhibitors of the Hill reaction. Plant Physiol 1961, 36:788-803.
23. Haseman J., Arnold J., Eustis S. Tumor incidences in Fischer 344 rats: NTP historical data. Pathology of the Fischer Rat 1990, 555-564. Academic Press, San Diego, CA. G.A. Boorman, S.L. Eustis, M.R. Elwell, C.A. Montgomery, W.F. MacKenzie (Eds.).
24. Hauswirth J.W., Wetzel L.T. Toxicity characteristics of the 2-chlorotriazines atrazine and simazine. Triazine Herbicides: Risk Assessment 1998, 370-383. American Chemical Society, Washington, DC, ACS Symposium Series 683. Chapter 29. L.G. Ballantine, J.E. McFarland, D.S. Hackett (Eds.).
25. Huang H.H., Steger R.W., Bruni J.F., Meites J. Patterns of sex steroid and gonadotropin secretion in aging female rats. Endocrinology 1978, 103:1855-1859.
26. World Health Organization International Agency for Research on Cancer. Lyon, France 1999, Vol. 73:59-113. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
27. World Health Organization International Agency for Research on Cancer. Lyon, France 1999, Vol. 73:625-640. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
28. Innes J.A.K., Ulland B.K., Valerio M.G., Petrucelli L., Fishbein L., Hart E.R., Pallota A.J., Bates R.R., Falk H.L., Gait A., Klein M., Mitchell I., Peters J. Bioassays of pesticides and industrial chemicals for tumorigenicity in mice: A preliminary note. J. Natl. Cancer Inst. 1969, 4:1101-1114.
29. Laws S.C., Ferrell J.M., Stoker T.E., Schmid J., Cooper R.L. The effects of atrazine on female Wistar rats: An evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol. Scl. 2000, 58:366-376.
30. Lu K.H., Hopper B.R., Vargo T.M., Yen S.S.C. Chronological changes in sex steroid, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states. Biol. Reprod. 1979, 21:193-203.
31. Lu J.K.H., Damassa D.A., Gilman D.P., Judd H.L., Sawyer C.H. Differential patterns of gonadotropin responses to ovarian steroids and to LH-releasing hormone between constant-estrous and pseudopregnant states in aging rats. Biol. Reprod. 1980, 23:345-351.
32. Maurer R.A. Cellular regulation of secretion and release. Regulation of Prolactin Gene Expression 1982, 267-300. Academic Press, New York. P.M. Conn (Ed.).
33. McLachlan J.A., Newbold R.R. Estrogens and development. Environ. Health Perspect. 1987, 75:25-27.
34. McMullin T.S., Andersen M.E., Nagahara A., Lund T.D., Pak T., Handa R.J., Hanneman W.H. Evidence that atrazine and diaminochlorotriazine inhibit the estrogen-progesterone induced surge of luteinizing hormone in female Sprague-Dawley rats without changing estrogen receptor action. Toxicol. Sci. 2004, 79:178-286.
35. Meites J., Huang H.H., Simpkins J.W. Recent studies on neuroendocrine control of reproductive senescence in rats. The Aging Reproductive System 1977, 213-235. Raven Press, New York. E.L. Schneider (Ed.).
36. Nicosia S.V. Ovarian changes during the climacteric. Aging, Reproduction and the Climacteric 1986, 179-199. Plenum Press, New York. L. Mastroianni, C.A. Paulsen (Eds.).
37. Noble R.L., Cutts J.H. Mammary tumors of the rat: A review. Cancer Res. 1959, 19:1125-1139.
38. Ousterhout J., Struck R.F., Nelson J.A. Estrogenic activities of methoxychlor metabolites. Biochem. Pharmacol. 1981, 30:2869-2871.
39. Plewa M.J., Wagner E.D., Gentile G.J., Gentile J.M. An evaluation of the genotoxic properties of herbicides following plant and animal activation. Mutat. Res. 1984, 136:233-245.
40. Rayner J.L., Wood C., Fenton S.E. Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine. Toxicol. Appl. Pharmacol 2004, 195:23-34.
41. Russo I.H., Russo J. Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 1996, 104:938-967.
42. Simpkins J.W. Changes in hypothalamic hypophysiotropic hormones and neurotransmitters during aging. Neuroendocrinology of Aging 1983, 41-59. Plenum Press, New York. J. Meites (Ed.).
43. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-screen assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 1995, 104(Suppl. 7):113-122.
44. Stevens J.T., Breckenridge C.B., Wetzel L.T., Gillis J.H., Luempert L.G., Eldridge J.C. Hypothesis for mammary tumori- genesis in Sprague-Dawley rats exposed to certain triazine herbicides. J. Toxicol. Environ. Health 1994, 43:139-154.
45. Stevens J.T., Breckenridge C.B., Wetzel L.T., Werner C., Luempert L.G., Thakur A.Y., Eldridge J.C. A risk characterization for atrazine: Oncogenicity profile and mode of action. J. Toxicol. Environ. Health 1998, 55:101-141.
46. Stevens J.T., Breckenridge C.B., Wetzel L.T., Thakur A.J., Liu C., Werner C., Luempert L.C., Eldridge J.C. A risk characterization for atrazine: Oncogenicity profile. Part A. J. Toxicol. Environ. Health. Part A 1999, 56:69-109.
47. Sielken R.L., Valdez-Flores C., Holden L.R., Breckenridge C., Stevens J. Statistical inferences about the mechanism of action in carcinogenicity studies. Scand. J. Work Environ. Health 2005, 31(Suppl. 1):151-155.
48. Stoker T.E., Laws S.C., Guidici D.L., Cooper R.L. The effect of atrazine on puberty in male Wistar rats: An evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol. Sci. 2000, 58:50-59.
49. Tanaka Y., Katayama K. Failure of positive feedback on the hypothalamus-pituitary-system in aged-women and its recovery in estrogen treatment. Acta Obstet. Gynecol. Jpn. 1982, 34:1907-1915.
50. Tennant M.K., Hill D.S., Eldridge J.C., Wetzel L.T., Breckenridge C.B., Stevens J.T. Possible antiestrogenic properties of chloro-s-triazines in rat uterus. J. Toxicol. Environ. Health 1994, 43:183-196.
51. Tennant M.K., Hill D.S., Eldridge J.C., Wetzel L.T., Breckenridge C.B., Stevens J.T. Chloro- s-triazine antagonism of estrogen action: Limited interaction with estrogen receptor binding. J. Toxicol. Environ. Health 1994, 43:197-211.
52. Tezak Z., Simic B., Kniewald J. Effect of pesticides on estradiol receptor complex formation in rat uterus cytosol. Fund. Chem. Toxicol. 1992, 30:879-885.
53. Thompson H.J., Ronan A.M. Effect of D, L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 1987, 1:2003-2006.
54. Tischer W., Strotmann H. Relationship between inhibitor binding by chloroplasts and inhibition of photosynthetic electron transport. Biochem. Biophys. Acta 1977, 460:113-125.
55. Tran D.Q., McLachlan J.A., Arnold S.F. The inhibition of estrogen receptor-mediated responses by chloro- s-triazine-derived compounds is dependent on estradiol concentration in yeast. Biochem. Biophys. Res. Comm. 1996, 221:140-146.
56. Trentacoste S.V., Friedman A.S., Youker R.T., Breckenridge C.B., Zirkin B.R. Atrazine effects on testosterone levels and androgen-dependent reproductive organs in prepubertal male rats. J. Androl. 2001, 22:142-148.
57. Uphouse L. Effects of chlordecone on neuroendocrine function of female rats. Neurotoxicology 1985, 6:191-210.
58. Interim Reregistration Eligibility Decision (IRED) 2003, USEPA, Docket Number 0062.
59. Welsch C.W. Host factors affecting growth of carcinogen-induced mammary carcinomas. A review and tribute to Charles Benton Huggins. Cancer Res. 1985, 43:3415-3443.
60. Welsch C.W. Rodent models to examine in vivo hormonal regulation of mammary gland tumorigenesis. Cellular and Molecular Biology of Mammary Cancer 1987, 179-199. Plenum Press, New York.
61. Welsch C.W., Jenkins T.W., Meites J. Increased incidence of mammary tumors in the female rat grafted with multiple pitui- taries. Cancer Res. 1970, 30:1024-1029.
62. Wetzel L.T., Luempert L.G., Breckenridge C.B., Tisdel M.O., Stevens J.T., Thakur A.K., Extrom P.J., Eldridge J.C. Chronic effects of atrazine on estrus and mammary gland formation in female Sprague-Dawley and Fischer-344 rats. J. Toxicol. Environ. Health 1994, 43:169-182.
63. Wise P.M. Norepinephrine and dopamine activity in microdissected brain areas of the middle-aged and young rat on proestrus. Biol. Reprod. 1982, 21:562-574.
64. Wise P.M. Estradiol-induced daily luteinizing hormone and prolactin surges in young and middle-aged rats: Correlations with age-related changes in pituitary responsiveness and catecholamine turnover rates in microdissected brain areas. Endocrinology 1984, 115:801-809.